<DOC>
	<DOCNO>NCT01573143</DOCNO>
	<brief_summary>The purpose STICS trial ( Statin Therapy In Cardiac Surgery ) test whether perioperative treatment Rosuvastatin 20 mg daily prevents post-operative atrial fibrillation reduces perioperative irreversible myocardial damage patient undergoing elective cardiac surgery .</brief_summary>
	<brief_title>Statin Therapy In Cardiac Surgery</brief_title>
	<detailed_description>Evidence pre- perioperative statin treatment may reduce occurrence post-operative atrial fibrillation improve clinical outcome patient undergoing coronary artery bypass graft ( CABG ) major vascular surgery largely generate observational study . In recent meta-analysis 6 randomize trial ( 2 postoperative atrial fibrillation ( AF ) predefined outcome ) evaluate use perioperative statin treatment patient undergoing cardiac surgery ( n=651 patient total - study size 40 200 patient ) , statin use find reduce patient ' relative risk develop postoperative AF 43 % ( RR 0.57 , 95 % CI 0.45,0.72 ) absolute risk 14 % ( 95 % CI 8 % ,20 % ) . Although finding would consistent rapid , possibly , lipid-independent antiarrhythmic effect statin , important limitation ( e.g. , single-centre , small size , lack continuous ECG monitoring , mostly `` ancillary '' finding '' ) less bearing current clinical practice , mostly include statin-naïve patient . For reason , recent guideline management AF give strong recommendation use statins prevention postoperative AF . Thus , whether intensive statin treatment perioperative period associate prevention AF , cardio protection , improve clinical outcome remain demonstrate .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>Adult patient await elective cardiac surgery willing able give inform consent participation study sinus rhythm take antiarrhythmic medication , betaadrenergic block agent , time surgery . History obstructive hepatobiliary disease serious hepatic disease Untreated hypothyroidism Creatinine &gt; 200 umol/L Personal family history hereditary muscle disorder Known intolerance statin history muscle toxicity fibrates statin . Ongoing use fibrates , niacin agent strong inhibitor cytochrome P450 Pglycoprotein within month precede randomization ( cyclosporine , oral azole antifungal , macrolide antibiotic , protease inhibitor , nefazodone , amiodarone ≥ 1L/day grapefruit juice ) Significant mitral valve disease ( moderate severe mitral regurgitationeg . &gt; grade II and/or mitral stenosis &amp; mitral annular calcification ) . Patients treat antiarrhythmic agent ( betaadrenergic receptor blocker ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Surgical Procedures , Cardiac</keyword>
	<keyword>Hydroxymethylglutaryl-CoA Reductase Inhibitors</keyword>
	<keyword>Rosuvastatin</keyword>
	<keyword>Post operative atrial fibrillation</keyword>
</DOC>